A 68-year-old ex-smoker (40 pack-years, quit 5 years ago) has chronic cough and exertional dyspnoea. Spirometry confirms COPD with post-bronchodilator...

Question

A 68-year-old ex-smoker (40 pack-years, quit 5 years ago) has chronic cough and exertional dyspnoea. Spirometry confirms COPD with post-bronchodilator FEV1 65% predicted. He has had one mild exacerbation in the last year. According to the 2023 CTS COPD guideline, what is the preferred initial maintenance pharmacologic therapy?

Accepted Answer

Dual long-acting bronchodilator therapy with LAMA/LABA

Answer

Short-acting bronchodilator as needed only

Answer

Long-acting muscarinic antagonist (LAMA) or long-acting beta agonist (LABA) monotherapy

Answer

Inhaled corticosteroid monotherapy

Answer

ICS/LABA combination as first-line

ca-mccqe1 MCQ (SBA): Stable COPD pharmacologic management